Black Diamond Therapeutics Aktie
WKN DE: A2PYWB / ISIN: US09203E1055
06.03.2025 22:46:51
|
Black Diamond Therapeutics Q4 Loss Decreases, Beats Estimates
(RTTNews) - Black Diamond Therapeutics (BDTX) revealed Loss for fourth quarter that decreased from last year and beat the Street estimates.
The company's earnings came in at -$15.99 million, or -$0.28 per share. This compares with -$19.41 million, or -$0.34 per share, last year.
Analysts on average had expected the company to earn -$0.33 per share. Analysts' estimates typically exclude special items.
Black Diamond Therapeutics earnings at a glance (GAAP) :
-Earnings: -$15.99 Mln. vs. -$19.41 Mln. last year. -EPS: -$0.28 vs. -$0.34 last year.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Black Diamond Therapeutics Inc Registered Shsmehr Nachrichten
Keine Nachrichten verfügbar. |
Analysen zu Black Diamond Therapeutics Inc Registered Shsmehr Analysen
Aktien in diesem Artikel
Black Diamond Therapeutics Inc Registered Shs | 1,56 | -3,11% |
|